Posts

INCREASE IN NETs INCIDENCE IN THE LAST 4 DECADES

ELEVATED LIVER CANCER RISK EVEN AFTER HBV CLEARANCE

CURE FOR METASTATIC PROSTATE CANCER? NOT YET THE CASE

REGORAFENIB APPROVED FOR SECOND LINE TREATMENT OF HCC

PREVENTING FRACTURES IN PATIENTS RECEIVING AROMATASE INHIBITORS

MIDOSTAURIN APPROVED FOR FLT3+ AML

AXILLARY pCR AFTER NEOADJUVANT CHEMOTHERAPY AFTER BREAST pCR

BRIGATINIB APPROVED FOR ALK+ NSCLC

LOCAL THERAPY INCREASE SURVIVAL IN PATIENTS WITH COLORECTAL CANCER AND LIVER METASTASES

ASCO GUIDELINES FOR PROSTATE CANCER

A NEGATIVE TRIAL OF PCI IN SCLC

IMMUNOTHERAPY FOR FIRST LINE TREATMENT OF BLADDER CANCER

SCALP COOLING DEVICE FOR BREAST CANCER PATIENTS

A VACCINE NEAR APPROVAL FOR GLIOBLASTOMA